Evidence map›Paper›PMID 35422706›Full record

ArticleFrontiers in pharmacology2022

Targeting the Interaction of GABA

Musadiq A Bhat, Abolghasem Esmaeili, Elena Neumann, Karthik Balakrishnan, Dietmar Benke

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Restoring GABAFrontiers in molecular neuroscience · 2024
    Article
  6. Restoration of GABANeural regeneration research · 2023
    Article
  7. Protein phosphatase 2A regulation of GABAFrontiers in molecular neuroscience · 2022
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Musadiq A BhatInstitute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
Abolghasem EsmaeiliDepartment of Cell and Molecular Biology & Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, Iran.
Elena NeumannInstitute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
Karthik BalakrishnanInstitute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
Dietmar BenkeInstitute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
University of Zurich · CHETH Zurich · CHUniversity of Isfahan · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

GABA

Indexed as

cerebral ischemiaCHOPGABAB receptorinterfering peptideneuroprotectionoxygen and glucose deprivation (OGD)

Identifiers

PMID35422706
PMCPMC9002115
OpenAlexW4221085898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.